Why the CVS–Mass General Deal Would Likely Increase Spending More Than Access

A Massachusetts regulator is warning that CVS and Mass General Brigham’s proposed MinuteClinic partnership could drive up healthcare spending by at least $40 million annually, largely through steering patients into a higher-priced system. Experts said the deal might improve convenience for some patients but is unlikely to meaningfully expand access — and could ultimately strengthen…

Read More

Are drug prices value-based?

One of the central tensions in pharmaceutical policy is the gap between what a drug is worth and what it actually costs. In theory, a drug’s price should reflect its value — its ability to improve health outcomes relative to the next best alternative. In practice, list prices are set by manufacturers, net prices are shaped by opaque…

Read More

Come help save democracy!

Tuesday, May 5 | 8-9 pm ET, 5-6 pm PT  Protecting Healthcare and Our Democracy: A conversation with Mandy Cohen, Former Director, Centers for Disease Control and Prevention PLUS former NC Governor Roy Cooper & Dr. Donald Berwick, IHI founder/former president REGISTER & DONATE A matching fund of $70,000 is in effect for this event! This…

Read More